MedPath

A Study of HIV-Disease Development in Aging

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00006144
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to better understand the relationship between age and HIV disease progression.

This study will explore the possible relationship between age and HIV disease progression. Older age is an important risk factor for faster disease development, but older people may respond better to combination drug therapy. This relationship needs to be understood better.

Detailed Description

Older age is an important risk factor for accelerated HIV-disease progression. However, the virologic response to highly active antiretroviral therapy (HAART) may be superior in older persons. A better understanding of the immunologic, virologic, and behavioral mechanisms that underlie these age-related differences may help to elucidate critical immune responses that are necessary to control the progression of HIV-disease.

Patients are grouped according to age. Group A consists of patients between the ages of 13 and 30 years. Group B consists of patients age 45 years or older. All patients receive open-label lopinavir/ritonavir (LPV/RTV) plus emtricitabine (FTC) plus stavudine (d4T) for 96 \[AS PER AMENDMENT 06/04/02: 192\] weeks. Study visits occur at pre-entry, entry, and Weeks 4, 8, 12, 16, and 24 then every 12 weeks thereafter through Week 96 \[AS PER AMENDMENT 06/04/02: Week 192\]. Clinical assessments, safety laboratory tests, CD4 cell count monitoring, lymphocyte phenotyping, and HIV-1 RNA determinations are performed routinely. Blood samples are stored for further immunology and virology studies. Patients may volunteer to participate in virology substudy A5020s and either immunology substudy A5016s or A5017s \[AS PER AMENDMENT 06/04/02: Substudy A5017s has been eliminated.\]

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (45)

Santa Clara Valley Med. Ctr.

๐Ÿ‡บ๐Ÿ‡ธ

San Jose, California, United States

Mt. Sinai Med. Ctr. A0404 CRS

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Columbia Univ., HIV Prevention and Treatment Medical Ctr.

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Mt.Sinai Med. Ctr. A1009 CRS

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Univ. of Rochester ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

The Miriam Hosp. ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Rhode Island Hosp.

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

Puerto Rico-AIDS CRS

๐Ÿ‡ต๐Ÿ‡ท

San Juan, Puerto Rico

Stanford CRS

๐Ÿ‡บ๐Ÿ‡ธ

Palo Alto, California, United States

San Mateo County AIDS Program

๐Ÿ‡บ๐Ÿ‡ธ

San Mateo, California, United States

Beth Israel Med. Ctr., ACTU

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Washington U CRS

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

Trillium Health ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

NY Univ. HIV/AIDS CRS

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

AIDS Care CRS

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

University of Colorado Hospital CRS

๐Ÿ‡บ๐Ÿ‡ธ

Aurora, Colorado, United States

Univ. of Miami AIDS CRS

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Univ. of Hawaii at Manoa, Leahi Hosp.

๐Ÿ‡บ๐Ÿ‡ธ

Honolulu, Hawaii, United States

Rush Univ. Med. Ctr. ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Methodist Hosp. of Indiana

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Bmc Actg Crs

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Unc Aids Crs

๐Ÿ‡บ๐Ÿ‡ธ

Chapel Hill, North Carolina, United States

Duke Univ. Med. Ctr. Adult CRS

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Case CRS

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

USC CRS

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Ucsf Aids Crs

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

Marin County Dept. of Health & Human Services, HIV/AIDS Program & Specialty Clinic

๐Ÿ‡บ๐Ÿ‡ธ

San Rafael, California, United States

Queens Med. Ctr.

๐Ÿ‡บ๐Ÿ‡ธ

Honolulu, Hawaii, United States

Northwestern University CRS

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Indiana Univ. School of Medicine, Infectious Disease Research Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Indiana Univ. School of Medicine, Wishard Memorial

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Johns Hopkins Adult AIDS CRS

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Massachusetts General Hospital ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Brigham and Women's Hosp. ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Beth Israel Deaconess Med. Ctr., ACTG CRS

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

SSTAR, Family Healthcare Ctr.

๐Ÿ‡บ๐Ÿ‡ธ

Fall River, Massachusetts, United States

University of Minnesota, ACTU

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis, Minnesota, United States

MetroHealth CRS

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

The Ohio State University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

Hosp. of the Univ. of Pennsylvania CRS

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Philadelphia Veterans Admin. Med. Ctr. A6205 CRS

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Vanderbilt Therapeutics CRS

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Univ. of Texas Southwestern Med. Ctr., Amelia Court Continuity Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Univ. of Texas Medical Branch, ACTU

๐Ÿ‡บ๐Ÿ‡ธ

Galveston, Texas, United States

University of Washington AIDS CRS

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath